Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioTelemetry

Explore full profile

At BioTelemetry, we fuel the advancement of mobile health services by providing leading technology and services

Malvern, United StatesFounded 1994Biotech & Life Sciences
Valuation $2.80B Market cap · 2026
Revenue $450M Latest reported FY

At a glance

Status
Listed
Founded
1994
Headquarters
Malvern, United States
Listing
IPO 2013
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tier

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Investors

5 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series B and later5 investors entered at this stage

  • IDEO
  • Biofrontier Partners
  • Sanderling Ventures
  • Guidant Corporation
  • Hambrecht & Quist Capital Management

Talent

Book a demo to see the people
Employees mapped 591 incl. 3 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States94.6%
🇲🇰 North Macedonia1%
🇮🇳 India1%
🇧🇴 Bolivia1%
🇦🇷 Argentina1%
Top 5 of 7 shown
Web traffic by country
9.6K monthly visits
across markets
🇺🇸 United States86.5%
🇮🇳 India11.5%
🇨🇦 Canada2.1%
🇦🇷 Argentina0%
🇮🇹 Italy0%
Top 5 markets shown

Patents

Estimated portfolio value
$9M

21 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Investments and acquisitions

Disclosed deals where BioTelemetry was the backer or acquirer, 2012–2019. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

6 deals across BioTelemetry's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        Where BioTelemetry deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        BioTelemetry's portfolio, mapped.

        Stage
        Period
        6 of 6 deals

        Market sentiment

        Posts on X, past 7 days

        An AI-synthesised read of the highest-engagement posts about BioTelemetry on X, ranked by likes and reposts, corporate channels excluded.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See BioTelemetry on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

        Book a demo Explore company profiles